Cosmax Group, 1,150 R&D Personnel... "Leading the Beauty and Health Market"

Over 5% of Sales Invested in R&D
Approximately 1,500 Domestic and International Patent Applications
More than 8,000 New Products Launched Annually

Cosmax Group's research and development (R&D) personnel have reached nearly 1,150. Cosmax Group plans to continue developing beauty & health innovative technologies through continuous R&D investment, including securing outstanding talent.

Cosmax, a cosmetics original design manufacturer (ODM), regards its in-house research organization, the R&I (Research & Innovation) Center, as a core driving force. Since its founding, it has invested about 5% of its annual sales in the R&D sector and annually introduces innovative technologies through ▲active industry-academia collaboration (Open R&I) with leading domestic and international research institutions ▲establishment of a global R&I system.

Cosmax has established a ‘virtuous cycle of R&D’ structure by reinvesting profits generated from new technology development into R&D, leading to new patent applications. As of June, the cumulative number of patents filed by Cosmax in domestic and global markets totals approximately 1,500, with about 600 patents registered. The number of new products Cosmax launches annually exceeds 8,000. Representative items such as CC cream and gel eyeliner were first developed by Cosmax, pioneering new categories in the cosmetics market.

Within Cosmax Group, the health functional food divisions Cosmax NBT and Cosmax Bio possess a total of 16 individually recognized ingredients based on efficacy standards, including chajeugi, hydrangea, and ashwagandha. Last year, to strengthen synergy between headquarters and overseas subsidiaries, the GCC (Global Corporate Center) was established. In the research sector, an organic cooperative system has been built centered on the Pangyo R&I Center, collaborating with overseas subsidiaries in China, the United States, Indonesia, and Thailand.

A Cosmax Group official stated, “The driving force behind the group’s growth has been the R&D capabilities emphasized since its founding,” adding, “We will continuously secure top-level research and development capabilities to solidify our position as the global number one.”